1. Fingerhut A. What counts most in the lymph node count for colorectal cancer?. <em>Surg Innov.</em> 2012;19(3):213-215.
2. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. <em>Ann Surg Oncol.</em> 2010;17(6):1471-1474.
3. Song YX, Gao P, Wang ZN, et al. Which is the most suitable classification for colorectal cancer, log odds, the number, or the ratio of positive lymph nodes?. <em>PLoS One.</em> 2011;6(12):e28937.
4. Scabini S. Sentinel node biopsy in colorectal cancer: must we believe it?. <em>World J Gastrointest Surg.</em> 2010;2(1):6-8.
5. Leung AM, Scharf AW, Vu HN. Factors affecting number of lymph nodes harvested in colorectal cancer. <em>J Surg Res.</em> 2011;168(2):224-230.
6. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. <em>J Natl Cancer Inst.</em> 2007;99(6):433-441.
7. Noura S, Ohue M, Kano S, et al. Impact of metastatic lymph node ratio in node-positive colorectal cancer. <em>World J Gastrointest Surg.</em> 2010;2(3): 70-77.
8. McDonald JR, Renehan AG, O’Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. <em>World J Gastrointest Surg.</em> 2012;4(1):9-19.
9. Betge J, Harbaum L, Pollheimer MJ, et al. Lymph node retrieval in colorectal cancer: determining factors and prognostic significance. <em>Int J Colorectal Dis.</em> 2017;32(7):991-998.
10. Chen YJ, Yeh ST, Kao PS, Ou LH, Lin CS. A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection. <em>World J Surg Oncol.</em> 2020;18(1):97.
11. Qiao Y, Zhu J, Han T, et al. Finding the minimum number of retrieved lymph nodes in node-negative colorectal cancer using real-world data and the SEER database. <em>Int J Surg.</em> 2023;109(12):4173-4184.
12. Kuo YH, Lee KF, Chin CC, Huang WS, Yeh CH, Wang JY. Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage III colon cancer?. <em>Int J Colorectal Dis.</em> 2012;27(12):1625-1635.
13. Wong SL. Lymph node counts and survival rates after resection for colon and rectal cancer. <em>Gastrointest Cancer Res.</em> 2009;3(2 Suppl): S33-S35.
14. Orsenigo E, Gasparini G, Carlucci M. Clinicopathological factors influencing lymph node yield in colorectal cancer: a retrospective study. <em>Gastroenterol Res Pract.</em> 2019;2019:5197914.
15. Nelson H, Petrelli N, Carlin A, et a. National cancer institute expert panel. Guidelines 2000 for colon and rectal cancer surgery. <em>J Natl Cancer Inst.</em> 2001;93(8):583-96.
16. Feng H, Lyu Z, Liang W, et al. Optimal examined lymph node count in node-negative colon cancer should be determined. <em>Future Oncol.</em> 2021; 17(29):3865-3872.
17. Wu W, Li D, Ma W, et al. Examining more lymph nodes may improve the prognosis of patients with right colon cancer: determining the optimal minimum lymph node count. <em>Cancer Control.</em> 2021;28: 10732748211064034.
18. Lee L, Erkan A, Alhassan N, et al. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?. <em>Surg Oncol.</em> 2018;27(3):449-455.
19. Hayes IP, Milanzi E, Gibbs P, Faragher I, Reece JC. Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?. <em>J Surg Oncol.</em> 2022;126(3):523-534.
20. de Lacy FB, Chadi SA, Berho M, et al. The future of rectal cancer surgery: a narrative review of an International Symposium. <em>Surg Innov.</em> 2018;25(5):525-535.
21. Benz SR, Feder IS, Vollmer S, et al. Complete mesocolic excision for right colonic cancer: prospective multicentre study. <em>Br J Surg.</em> 2022; 110(1):98-105.
22. Li Destri G, Di Carlo I, Scilletta R, Scilletta B, Puleo S. Colorectal cancer and lymph nodes: the obsession with the number 12. <em>World J Gastroenterol.</em> 2014;20(8):1951-1960.
23. Biondo S, Gálvez A, Ramírez E, Frago R, Kreisler E. Emergency surgery for obstructing and perforated colon cancer: patterns of recurrence and prognostic factors. <em>Tech Coloproctol.</em> 2019:1141-1161.
24. Chen TM, Huang YT, Wang GC. Outcome of colon cancer initially presenting as colon perforation and obstruction. <em>World J Surg Oncol.</em> 2017;15(1):164.
25. Asano H, Fukano H, Takagi M, Takayama T. Risk factors for the recurrence of stage II perforated colorectal cancer: a retrospective observational study. <em>Asian J Surg.</em> 2023;46(1):201-206.
26. Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. <em>World J Emerg Surg.</em> 2018;13:36.
27. Yang KM, Jeong MJ, Yoon KH, Jung YT, Kwak JY. Oncologic outcome of colon cancer with perforation and obstruction. <em>BMC Gastroenterol.</em> 2022;22(1):247.
28. Ha GS, Kim YW, Choi EH, Kim IY. Factors associated with the lack of adjuvant chemotherapy following curative surgery for stage ii and iii colon cancer: a Korean national cohort study. <em>Anticancer Res.</em> 2017; 37(2):915-922.
29. Kim CH, Bae JH, Lee CS, et al. Which prognostic factors are important for long-term outcomes in symptomatic obstructive colon cancer? A multi-institutional retrospective cohort study. <em>J Minim Invasive Surg.</em> 2021;24(3):128-138.
30. Kim CH, Bae JH, Lee CS, et al. Which prognostic factors are important for long-term outcomes in symptomatic obstructive colon cancer? A multi-institutional retrospective cohort study. <em>J Minim Invasive Surg.</em> 2021;24(3):128-138.
31. Ha GS, Kim YW, Choi EH, Kim IY. Factors associated with the lack of adjuvant chemotherapy following curative surgery for stage ii and iii colon cancer: a Korean National cohort study. <em>Anticancer Res.</em> 2017; 37(2):915-922.
32. Björkman K, Mustonen H, Kaprio T, et al. CA125: a superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. <em>Tumour Biol.</em> 2021;43(1):57-70.
33. Holt J, Schwalb H, Elbourne H, Te Marvelde L, Reid C. Risk factors for recurrence in colorectal cancer: a retrospective analysis in a regional Australian hospital. <em>ANZ J Surg.</em> 2021;91(11):2482-2486.
34. Aguiar Junior S, Oliveira MM, Silva DRME, Mello CAL, Calsavara VF, Curado MP. Survival of patients with colorectal cancer in a cancer center. <em>Arq Gastroenterol.</em> 2020;57(2):172-177.
35. Mislang AR, Di Donato S, Hubbard J, et al. Nutritional management of older adults with gastrointestinal cancers: an International Society of Geriatric Oncology (SIOG) review paper. <em>J Geriatr Oncol.</em> 2018;9(4):382-392.
36. Yamano T, Yamauchi S, Kimura K, et al. Japanese study group for postoperative follow-up of colorectal cancer. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: a retrospective multicentre study. <em>Eur J Cancer.</em> 2017;81:90-101.